The Emerging Roles of Surfactant Protein-A in Asthma
Open Access
- 1 January 2018
- journal article
- Published by OMICS Publishing Group in Alternative & Integrative Medicine
Abstract
Asthma remains one of the most common respiratory diseases in both children and adults affecting up to 10% of the US population. Asthma is characterized by persistent symptoms, airway inflammation, airflow limitation and frequent exacerbations. Eosinophils are a key immune cell present in a large majority of asthmatics and their presence and dysregulation are clinically associated with more severe asthma. Surfactant protein A (SP-A) provides a first-line of defense in pulmonary innate immunity by virtue of its role in pathogen opsonization. SP-A is known to specifically bind to Mycoplasma pneumoniae (Mp), a pathogen associated with asthma exacerbations, and functions to attenuate Mp pathogenicity and abrogate lung inflammation. In addition, SP-A has been shown to inhibit Mp-induced eosinophil peroxidase (EPO) release, a toxic product that can compromise the integrity of the delicate airway epithelia. We have determined that genetic variation in SP-A2 at position 223 that results in a glutamine (Q) to a lysine (K) substitution alters the ability of SP-A to inhibit EPO release and may offer a mechanistic explanation as to why some SP-A extracted from subjects with asthma is unable to carry out normal immune regulatory functions.Keywords
This publication has 31 references indexed in Scilit:
- Surfactant Protein-A Suppresses Eosinophil-Mediated Killing of Mycoplasma pneumoniae in Allergic LungsPLOS ONE, 2012
- Surfactant protein A is defective in abrogating inflammation in asthmaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Surfactant Protein-A Inhibits Mycoplasma-Induced Dendritic Cell Maturation through Regulation of HMGB-1 Cytokine ActivityThe Journal of Immunology, 2010
- Review: Collectins link innate and adaptive immunity in allergic airway diseaseInnate Immunity, 2010
- SP-A Preserves Airway Homeostasis During Mycoplasma pneumoniae Infection in MiceThe Journal of Immunology, 2009
- Immunomodulatory Roles of Surfactant Proteins A and D: Implications in Lung DiseaseProceedings of the American Thoracic Society, 2007
- Genetic Polymorphism of the Binding Domain of Surfactant Protein-A2 Increases Susceptibility to Meningococcal DiseaseClinical Infectious Diseases, 2006
- Immunoregulatory functions of surfactant proteinsNature Reviews Immunology, 2005
- Differences in Biochemical Properties and in Biological Function between Human SP-A1 and SP-A2 Variants, and the Impact of Ozone-Induced OxidationBiochemistry, 2004
- Chemokines in asthma: Cooperative interaction between chemokines and IL-13Journal of Allergy and Clinical Immunology, 2003